Katerina is an experienced scientific and executive leader, with over 30 years of experience in senior scientific positions in large pharma and biotech companies, including Bristol Myers Squibb (BMS), ...

“Capstan’s platform is tackling an unserved area of cardiovascular care for a patient population that has almost no other options,” said Mohr. “It has the potential to transform heart valve disease ...

A seasoned operations executive, Castle has a strong track record of driving growth through operations excellence and building high-performing teams in complex manufacturing environments, particularly ...

The SurTract Syringe will be distributed across hospitals, clinics, and emergency-care settings beginning in the first quarter of 2026. #image_title Terumo Medical Corporation, a wholly-owned ...

Caliway has completed the End-of-Phase 2 (EOP2) meeting with the U.S. FDA for CBL-514, the world's first investigational drug for large-area subcutaneous fat reduction developed under the 505(b)(1) ...

"The recognition of Breakthrough Device Designation for the eShunt System in pediatric aged patients demonstrates the profound need for treatment innovation in this patient population and reinforces ...

A device-based therapy for patients with uncontrolled hypertension whose blood pressure cannot be properly managed with lifestyle changes and medication Recor Medical, Inc. today announced that the ...

The VELYS SPINE system is designed to address the uniquely complex needs of spine surgeons; the system offers a customizable experience with pathology-specific workflows, aided by capabilities such as ...

Managing mealtime glucose takes planning, observation, and steady routines. NovoRapid Vial fits into many care plans as a fast-acting option used around meals. This guide explains timing, symptoms to ...

Conduction system pacing technique may promote greater ventricular synchrony and reduce long-term risk of heart failure associated with traditional right ventricular pacing Boston Scientific ...

This new clearance broadens the clinical utility of the Restrata platform, now supporting soft tissue reinforcement applications in addition to its previously cleared indications for wound healing.

16.3.25. Zenith Sales & Calibrations Pty Ltd.